Medical Devices Magyarország KFT
20160411B18_1 (china)
11.04.2023 7:55:18 00010101 : 20160619
Gender: female | Age: 50 | Weight(kg): 62 | Pulse: 60 | Resp.rate: 18 | Atm.pres: 760,8 |
LCA: 33,32 |
RCA: 33,14 |
LAC: 36,24 |
RAC: 36,27 |
ABD: 30,08 |
169,05 |
Preliminary computer conclusion about diagnosis:
Comprehensive cell mitosis regulation factor is changed. =3,558
It is necessary to get a consultation of a gastroenterologist (Gastroduodenitis should be verified).
Ischemic heart-disease is determined.
Width of the third ventricle of cerebrum.=7,34
Tiffeneau index has reduced till: 79,8 (Test Tiffeneau.)
Comprehensive cell mitosis regulation factor.↓
Myocardial blood flow.↓↓
Skin blood flow.↓
Blood flow of other organs.↑↑
pH of blood.↓
SH.↓
Basal pressure of Oddi’s sphincter↑
CO₂ elimination.↑
(CO₂) venous blood.↓
Test Tiffeneau.↓
Working rate of oxygen consumption.↑
Time of single load.↑↑
Myocardial oxygen consumption.↑
Low risk of atherosclerosis.
Average blood pressure (MAP). norm 60-100) =94,7
Colloid-Osmotic Pressure (COP). ↑
Disclaimer.
The above medical information is provided as a resource only and is not to be used or relied on for any diagnostic or treatment purposes. This information is not intended to be patient education, does not create any patient – physician relationship, and shouldn’t be used as a substitute for professional diagnosis and treatment. Any health decisions or guidance about specific medical condition are to be made only by Doctors or health care providers. In no circumstance, the device shall replace biochemical laboratory analysis. This device manufacturer expressly disclaims responsibility and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this report.
Signature of patient__________________
GDPR: I have been briefed on my rights and Privacy Policy based on the REGULATION (EU) 2016/679 (GDPR) regarding the processing and movement of the personal data, which are used for the purposes of non-invasive hemogram screening, provided by the software USPIH. I am aware of and agree with the condition that the data containing in the database of the software USPIH will not be disclosed and/or forwarded to unauthorised third parties except the following: a) to a personal data processor (a professional, who is responsible for carrying out an examination on site); b) to the respective/authorised staff of the manufacturer, whose duties includes elimination of bugs in the software USPIH, software update or other assistance related to the software USPIH on the request of the personal data processor; c) to governments, control agencies, regulatory authorities and others as permitted or required by law. I am aware of an ability to withdraw my consent at any time submitting a written statement in the place, where the service was provided. Thereof, I realise that my personal data will be deleted irrevocably and without a possibility of further applying, referring and analysing of such a data.
Signature of patient__________________
The following parameters were simultaneously captured to issue the above preliminary report.
No.: | Parameter: | Norm: | < | > | ||
1 | 2 | Erythrocytes RBC. x10¹²/l | 3,4 - 5 | 4,18 | ||
2 | 1 | Hemoglobin HGB. g/l | 120 - 160 | 125,39 | ||
3 | 88 | Hematocrit.HCT % | 35 - 49 | 37,72 | ||
4 | 12 | Thrombocytes. x10⁹/l | 150 - 400 | 236,24 | ||
5 | 4 | Leukocytes WBC. x10⁹/l | 3,2 - 10,2 | 4,50 | ||
6 | 3 | Lymphocytes. LYMPH % | 19 - 37 | 37,93 | ||
7 | 8 | Monocytes.MONO % | 3 - 8 | 5,51 | ||
8 | 42 | Glucose. mmol/l | 3,9 - 6,2 | 4,30 | ||
9 | 35 | Cholesterol total. mmol/l | 3,11 - 6,48 | 5,55 | ||
10 | 38 | Low-density lipoproteins (LDL). mmol/l | 1,81 - 4,9 | 3,16 | ||
11 | 40 | High-density lipoproteins (HDL). mmol/l | 0,85 - 2,28 | 1,32 | ||
12 | 41 | Triglycerides (TG). mmol/l | 0,55 - 1,85 | 1,68 | ||
13 | 25 | ALT. U/l | 5 - 30 | 12,87 | ||
14 | 24 | AST. U/l | 8 - 40 | 14,57 | ||
15 | 27 | Bilirubin, Total. μmol/l | 8,6 - 20,5 | 11,16 | ||
16 | 31 | Creatinine. μmol/l | 55 - 123 | 49,43 | ||
17 | 34 | Urea. mmol/l | 2,1 - 8,2 | 5,08 | ||
Hemogram: | ||||||
18 | 1 | Hemoglobin HGB. g/l | 120 - 160 | 125,39 | ||
19 | 2 | Erythrocytes RBC. x10¹²/l | 3,4 - 5 | 4,18 | ||
20 | 4 | Leukocytes WBC. x10⁹/l | 3,2 - 10,2 | 4,50 | ||
21 | 120 | Mean cell haemoglobin (MCH). pg | 26 - 32 | 30 | ||
22 | 121 | Mean cell volume (MCV). fl | 81 - 94 | 90 | ||
23 | 122 | Mean cell haemoglobin concentration (MCHC). g/l | 310 - 350 | 332 | ||
24 | 123 | CPB (Color index of blood). | 0,85 - 1,15 | 0,90 | ||
25 | 3 | Lymphocytes. LYMPH % | 19 - 37 | 37,93 | ||
26 | 5 | Segmented neutrophiles. NEUT % | 45 - 68 | 50,42 | ||
27 | 7 | Eosinophils. % | 1 - 5 | 3,07 | ||
28 | 8 | Monocytes.MONO % | 3 - 8 | 5,51 | ||
29 | 9 | Band neutrophiles. NEUT % | 1 - 6 | 3,07 | ||
30 | 6 | Erythrocyte sedimentation rate ESR. mm/h | 2 - 20 | 11,99 | ||
Blood coagulation: | ||||||
31 | 10 | Beginning of clotting (method of Lee-White). min | 0,5 - 2 | 02`46`` | ||
32 | 11 | End of clotting (method of Lee-White). min | 3 - 5 | 03`38`` | ||
33 | 12 | Thrombocytes. x10⁹/l | 150 - 400 | 236,24 | ||
34 | 86 | Fibrinogen. g/l | 2 - 4 | 1,83 | ||
35 | 87 | Prothrombin index (PI). % | 75 - 104 | 75,59 | ||
36 | 88 | Hematocrit.HCT % | 35 - 49 | 37,72 | ||
Electrolyte metabolism: | ||||||
37 | 13 | Calcium (Ca). mmol/l | 1,99 - 3,2 | 2,54 | ||
38 | 14 | Magnesium (Mg). mmol/l | 0,84 - 1,17 | 0,91 | ||
39 | 15 | Potassium (K). mmol/l | 3,34 - 4,96 | 3,82 | ||
40 | 16 | Sodium (Na). mmol/l | 136 - 145 | 141,95 | ||
41 | 128 | Chloride (Cl). mmol/l | 98 - 107 | 106,4 | ||
Functional parameters of stomach: | ||||||
42 | 17 | pH of gastric juice. | 1,2 - 1,7 | 1,37 | ||
43 | 19 | SH. | 7,32 - 7,4 | 6,60 | ||
44 | 20 | Basal pressure of Oddi’s sphincter mm Hg | 39 - 41 | 42,86 | ||
Carbohydrate metabolism: | ||||||
45 | 33 | Lactic acid. mmol/l | 0,5 - 2,22 | 1,97 | ||
46 | 42 | Glucose. mmol/l | 3,9 - 6,2 | 4,30 | ||
47 | 43 | Glycogen. mg% | 11,7 - 20,6 | 14,85 | ||
Liver function tests: | ||||||
48 | 22 | Aspartate transaminase (AST). mmol/l | 0,1 - 0,45 | 0,36 | ||
49 | 23 | Alanine transaminase (ALT). mmol/l | 0,1 - 0,68 | 0,22 | ||
50 | 26 | De Ritis ratio (AST/ALT). | 0,8 - 1,2 | 1,64 | ||
51 | 27 | Bilirubin, Total. μmol/l | 8,6 - 20,5 | 11,16 | ||
52 | 28 | Bilirubin, Direct. μmol/l | 1 - 6 | 2,49 | ||
53 | 29 | Bilirubin, Indirect. μmol/l | 1,7 - 10,2 | 8,68 | ||
54 | 130 | Alkaline phosphatase (ALP). μkat/L | 0,5 - 2,4 | 1,54 | ||
Protein metabolism: | ||||||
55 | 30 | Protein, Total. g/l | 60 - 85 | 77,73 | ||
56 | 133 | Serum albumin (ALB). g/l | 34 - 45 | 46,4 | ||
57 | 134 | Serum globulin (GLB). g/l | 20 - 45 | 31,4 | ||
58 | 138 | Colloid-Osmotic Pressure (COP). | ----- | 29,9 | ||
59 | 31 | Creatinine. μmol/l | 55 - 123 | 49,43 | ||
60 | 32 | Dopamine β-hydroxylase (DBH). nmol/ml/min | 28 - 32,5 | 29,45 | ||
61 | 34 | Urea. mmol/l | 2,1 - 8,2 | 5,08 | ||
62 | 126 | Transferrin. mg/dl | 204 - 380 | 181,19 | ||
Lipid metabolism: | ||||||
63 | 41 | Triglycerides (TG). mmol/l | 0,55 - 1,85 | 1,68 | ||
64 | 38 | Low-density lipoproteins (LDL). mmol/l | 1,81 - 4,9 | 3,16 | ||
65 | 39 | Very low-density lipoproteins (VLDL). mmol/l | 0,2 - 0,52 | 0,41 | ||
66 | 40 | High-density lipoproteins (HDL). mmol/l | 0,85 - 2,28 | 1,32 | ||
67 | 35 | Cholesterol total. mmol/l | 3,11 - 6,48 | 5,55 | ||
68 | 36 | β- lipoprotein. g/l | 17 - 55 | 42,34 | ||
69 | 37 | β- lipoprotein. mmol/l | 3 - 6 | 3,84 | ||
70 | 132 | Atherogenic Coefficient (AC). | 0,71 - 5,36 | 3,21 | ||
71 | 135 | Atherogenic index of plasma (AIP). | ----- | 0,105 | ||
Water metabolism: | ||||||
72 | 45 | Cellular water. % | 39 - 42 | 39,15 | ||
73 | 46 | Total water. % | 50 - 70 | 64,44 | ||
74 | 44 | Extracellular water. % | 21 - 23 | 23,13 | ||
Hormones: | ||||||
75 | 47 | Testosterone. μmol/24hours | 2,77 - 10,4 | 6,52 | ||
76 | 48 | Estrogen, Total . nmol/24hours | 78,98 - 376,95 | 102,78 | ||
77 | 49 | Thyroxine (T4),Total. nmol/l | 71 - 142 | 80,2 | ||
Enzymes: | ||||||
78 | 50 | Amylase (W.Т.Caraway). g/l*h | 12 - 32 | 15,43 | ||
79 | 51 | Acetylcholine. μg/ml | 81,1 - 92,1 | 71,02 | ||
80 | 52 | Acetylcholinesterase of erythrocytes. μmol/l | 220 - 278 | 254,35 | ||
81 | 54 | Tyrosine. mg*%[Zbarskiy B. I., 1972] | 1,4 - 1,8 | 1,46 | ||
82 | 55 | Creatine kinase MM (CK-MM). μmol/min/kg | 473 - 483 | 477,21 | ||
83 | 56 | Creatine kinase MB (CK-MB). μmol/min/kg | 35,1 - 38,1 | 36,74 | ||
Cell mitosis regulation: | ||||||
84 | 57 | Comprehensive cell mitosis regulation factor. | 3,7828 - 3,9372 | 3,5583 | ||
Internal blood flow, in % to total blood flow: | ||||||
85 | 64 | Myocardial blood flow. % | 4,32 - 5,02 | 3,79 | ||
86 | 65 | Muscular blood flow. % | 14,56 - 16,93 | 15,12 | ||
87 | 66 | Cerebral blood flow. % | 12,82 - 14,9 | 13,87 | ||
88 | 67 | Hepatoportal blood flow. % | 20,28 - 29,86 | 23,54 | ||
89 | 68 | Nephritic blood flow. % | 21,58 - 25,09 | 24,53 | ||
90 | 69 | Skin blood flow. % | 7,9 - 9,19 | 7,48 | ||
91 | 70 | Blood flow of other organs. % | 5,76 - 6,7 | 7,51 | ||
Internal blood flow, in ml/min: | ||||||
92 | 71 | Myocardial blood flow. ml/min | 250 - 290,5 | 219,11 | ||
93 | 72 | Muscular blood flow. ml/min | 930 - 1081,4 | 965,50 | ||
94 | 73 | Cerebral blood flow. ml/min | 750 - 871,68 | 811,11 | ||
95 | 74 | Hepatoportal blood flow. ml/min | 1690 - 2488,33 | 1 961,43 | ||
96 | 75 | Nephritic blood flow. ml/min | 1430 - 1662,6 | 1 625,73 | ||
97 | 76 | Skin blood flow. ml/min | 500 - 581,65 | 473,47 | ||
98 | 77 | Blood flow of other organs. ml/min | 375 - 436,19 | 488,75 | ||
Cerebral hemodynamics: | ||||||
99 | 82 | Cerebral blood flow on 100g of tissue. ml/100g | 50 - 55 | 51,96 | ||
100 | 83 | Blood flow per 1gr of thyroid gland. ml/g | 3,7 - 4,3 | 3,97 | ||
101 | 84 | Blood flow per 1gr of cerebral tissue. ml/g | 2,9 - 3,2 | 3,06 | ||
102 | 85 | Cerebral spinal fluid pressure (CSF). mm H₂O | 90 - 145 | 120,70 | ||
103 | 116 | Width of the third ventricle of cerebrum. mm | 4 - 6 | 7,34 | ||
Functional parameters of cardio-respiratory system: | ||||||
104 | 78 | Pulmonary vascular resistance (PVR). dyn/cm5*sec | 100 - 200 | 145,30 | ||
105 | 79 | Central venous pressure. mm H₂O | 70 - 150 | 66,19 | ||
106 | 80 | Time of pulmonary circulation. s | 16 - 23 | 19,32 | ||
107 | 81 | Time of systemic circulation. s | 4 - 5,5 | 4,58 | ||
108 | 21 | Energy Expenditure. kkal/kg/min | 0,123 - 0,43 | 0,499 | ||
109 | 61 | Oxygenation velocity of RBC. ml/min | 260 - 280 | 261,31 | ||
110 | 62 | Surface of gaseous exchange of RBC. m² | 3500 - 4300 | 3 250,1 | ||
111 | 63 | Deficit of circulatory blood. ml/kg | 0 - 250 | 39,25 | ||
112 | 89 | Vital capacity of lungs (VC). cm³. | 2500 - 4300 | 2 760,7 | ||
113 | 90 | Minute ventilation (VE) l/min | 4 - 12 | 7,97 | ||
114 | 91 | Functional residual capacity (FRC) cm³ | ----- | 1 480,8 | ||
115 | 92 | Peak expiratory flow (PEF). l/min | 74 - 116 | 78,86 | ||
116 | 93 | Test Tiffeneau. % | 86 - 109 | 79,76 | ||
117 | 94 | Working rate of oxygen consumption. % | 45 - 60 | 65,05 | ||
118 | 95 | Time of single load. min | 3 - 10 | 16,58 | ||
119 | 96 | Respiratory exchange ratio (RER). | 0,8 - 1,2 | 0,80 | ||
Oxygen transport and consumption: | ||||||
120 | 18 | pH of blood. | 7,36 - 7,45 | 7,35 | ||
121 | 59 | Volume of circulatory blood. ml/kg | 65 - 69 | 65,59 | ||
122 | 60 | Cardiac output (CO). l/min | 3,5 - 4,3 | 3,99 | ||
123 | 97 | Transportation of oxygen(O₂). ml/min | 900 - 1200 | 1 073,4 | ||
124 | 98 | Quantity of assimilated oxygen on 100 gr. of cerebral tissue. ml | 2,8 - 3,4 | 3,03 | ||
125 | 99 | Oxygen saturation in arterial blood (SaO₂). % | 95 - 98 | 96,28 | ||
126 | 100 | Oxygen consumption per kg of body weight. ml/min/kg | 4 - 6 | 4,35 | ||
127 | 101 | O₂ consumption.(VO₂) ml/min | 200 - 250 | 247,13 | ||
128 | 102 | Myocardial oxygen consumption. ml/min | 7 - 10 | 10,44 | ||
129 | 103 | Oxygen extraction index. | 0,26 - 0,34 | 0,3 | ||
Transport and elimination of CO₂: | ||||||
130 | 104 | CO₂ elimination. ml/min | 119 - 300 | 303,35 | ||
131 | 105 | (CO₂) in arterial blood. % | 32,5 - 46,6 | 38,42 | ||
132 | 106 | (CO₂) venous blood. % | 51 - 53 | 49,99 | ||
133 | 107 | Rate of CO₂ production. ml/min | 150 - 340 | 258,93 | ||
Functional parameters of cardio-vascular system: | ||||||
134 | 108 | Vascular Permeability Index. | 4,165 - 4,335 | 3,916 | ||
135 | 109 | Stroke volume (SV). ml | 60 - 80 | 58,81 | ||
136 | 110 | Interval PR. sec | 0,12 - 0,2 | 0,148 | ||
137 | 111 | Interval QT. sec | 0,355 - 0,4 | 0,378 | ||
138 | 112 | Interval QRS. sec | 0,065 - 0,1 | 0,089 | ||
139 | 113 | Left ventricular Stroke Work Index. % | 52 - 60 | 55,19 | ||
140 | 114 | Systolic arterial pressure. mm Hg | ----- | 125,11 | ||
141 | 115 | Diastolic arterial pressure. mm Hg | ----- | 79,46 | ||
142 | 136 | Average blood pressure (MAP). | ----- | 94,7 | ||
143 | 58 | Plasma density. g/l | 1048 - 1055 | 1 046,2 | ||
144 | 117 | Cardiac work. Joule | 0,692 - 0,788 | 0,75 | ||
145 | 137 | Thrombolysis in Myocardial Infarction (TIMI) Risk Index. | ----- | 12,0 | ||
146 | 140 | Shock Index (SI). | ----- | 0,48 | ||
------------------ | ||||||
147 | 118 | eGFR [MDRD]. ml/min/1.73m² | =>60 | 60,0 | ||
148 | 119 | Estimated creatinine clearance rate(eClCr)[Cockroft and Gault]. ml/min | 75 - 115 | 117,9 | ||
149 | 124 | Cystatin C (CysC). mg/l | 0,6 - 0,96 | 0,72 | ||
150 | 125 | BUN. mg/dl | 6 - 23 | 14 | ||
151 | 127 | Urine specific gravity. g/cm³ | 1020 - 1030 | 1 007,6 | ||
152 | 129 | Ceruloplasmin (CP). g/l | 0,16 - 0,6 | 0,66 | ||
153 | 131 | Intracranial pressure (ICP). mmHg | 7 - 15 | 8,8 | ||
154 | 139 | Actual blood supply index (IK). | ----- | 38,5 |
USPIH (For all countries excluding EU)